JP2018513194A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018513194A5 JP2018513194A5 JP2017555587A JP2017555587A JP2018513194A5 JP 2018513194 A5 JP2018513194 A5 JP 2018513194A5 JP 2017555587 A JP2017555587 A JP 2017555587A JP 2017555587 A JP2017555587 A JP 2017555587A JP 2018513194 A5 JP2018513194 A5 JP 2018513194A5
- Authority
- JP
- Japan
- Prior art keywords
- vibrio
- group
- infections
- compound according
- neisseria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 13
- 241000894006 Bacteria Species 0.000 claims 7
- 208000035143 Bacterial infection Diseases 0.000 claims 6
- 241000588653 Neisseria Species 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 241001138501 Salmonella enterica Species 0.000 claims 5
- 241000607598 Vibrio Species 0.000 claims 5
- 241000607516 Aeromonas caviae Species 0.000 claims 4
- 241000607574 Aeromonas veronii Species 0.000 claims 4
- 206010006448 Bronchiolitis Diseases 0.000 claims 4
- 206010012735 Diarrhoea Diseases 0.000 claims 4
- 208000005577 Gastroenteritis Diseases 0.000 claims 4
- 201000009906 Meningitis Diseases 0.000 claims 4
- 206010035664 Pneumonia Diseases 0.000 claims 4
- 241000589892 Treponema denticola Species 0.000 claims 4
- 241000607479 Yersinia pestis Species 0.000 claims 4
- 208000021240 acute bronchiolitis Diseases 0.000 claims 4
- 230000003115 biocidal effect Effects 0.000 claims 4
- 201000001371 inclusion conjunctivitis Diseases 0.000 claims 4
- 208000015181 infectious disease Diseases 0.000 claims 4
- 206010034674 peritonitis Diseases 0.000 claims 4
- 206010044325 trachoma Diseases 0.000 claims 4
- 241000589242 Legionella pneumophila Species 0.000 claims 3
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 claims 3
- 241000607253 Vibrio mimicus Species 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 229940115932 legionella pneumophila Drugs 0.000 claims 3
- 125000000962 organic group Chemical group 0.000 claims 3
- 241000607534 Aeromonas Species 0.000 claims 2
- 241000606749 Aggregatibacter actinomycetemcomitans Species 0.000 claims 2
- 208000010266 Aggressive Periodontitis Diseases 0.000 claims 2
- 241000606124 Bacteroides fragilis Species 0.000 claims 2
- 208000014912 Central Nervous System Infections Diseases 0.000 claims 2
- 241001647372 Chlamydia pneumoniae Species 0.000 claims 2
- 241000606153 Chlamydia trachomatis Species 0.000 claims 2
- 206010008631 Cholera Diseases 0.000 claims 2
- 208000001860 Eye Infections Diseases 0.000 claims 2
- 208000001951 Fetal Death Diseases 0.000 claims 2
- 206010055690 Foetal death Diseases 0.000 claims 2
- 206010017917 Gastroenteritis vibrio Diseases 0.000 claims 2
- 206010017964 Gastrointestinal infection Diseases 0.000 claims 2
- 206010018296 Gingivitis ulcerative Diseases 0.000 claims 2
- 206010018612 Gonorrhoea Diseases 0.000 claims 2
- 241000606768 Haemophilus influenzae Species 0.000 claims 2
- 241000588747 Klebsiella pneumoniae Species 0.000 claims 2
- 208000032376 Lung infection Diseases 0.000 claims 2
- 241000588655 Moraxella catarrhalis Species 0.000 claims 2
- 241000588645 Neisseria sicca Species 0.000 claims 2
- 208000005141 Otitis Diseases 0.000 claims 2
- 206010033078 Otitis media Diseases 0.000 claims 2
- 206010033971 Paratyphoid fever Diseases 0.000 claims 2
- 241000606856 Pasteurella multocida Species 0.000 claims 2
- 241001672678 Photobacterium damselae subsp. damselae Species 0.000 claims 2
- 206010035148 Plague Diseases 0.000 claims 2
- 241000192142 Proteobacteria Species 0.000 claims 2
- 241000589516 Pseudomonas Species 0.000 claims 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims 2
- 241000589630 Pseudomonas pseudoalcaligenes Species 0.000 claims 2
- 206010037660 Pyrexia Diseases 0.000 claims 2
- 206010057190 Respiratory tract infections Diseases 0.000 claims 2
- 241000499381 Salinivibrio costicola Species 0.000 claims 2
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 claims 2
- 206010040047 Sepsis Diseases 0.000 claims 2
- 241001135258 Serratia proteamaculans Species 0.000 claims 2
- 241000312057 Simkania negevensis Z Species 0.000 claims 2
- 241001135235 Tannerella forsythia Species 0.000 claims 2
- 208000037386 Typhoid Diseases 0.000 claims 2
- 208000025865 Ulcer Diseases 0.000 claims 2
- 206010046914 Vaginal infection Diseases 0.000 claims 2
- 201000008100 Vaginitis Diseases 0.000 claims 2
- 241000607626 Vibrio cholerae Species 0.000 claims 2
- 241000607296 Vibrio cincinnatiensis Species 0.000 claims 2
- 241000607291 Vibrio fluvialis Species 0.000 claims 2
- 241001148070 Vibrio furnissii Species 0.000 claims 2
- 241000607618 Vibrio harveyi Species 0.000 claims 2
- 241000607272 Vibrio parahaemolyticus Species 0.000 claims 2
- 241000607265 Vibrio vulnificus Species 0.000 claims 2
- 206010048038 Wound infection Diseases 0.000 claims 2
- 241000607477 Yersinia pseudotuberculosis Species 0.000 claims 2
- 241000606834 [Haemophilus] ducreyi Species 0.000 claims 2
- 208000012873 acute gastroenteritis Diseases 0.000 claims 2
- 208000033608 aggressive 1 periodontitis Diseases 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 2
- 206010006451 bronchitis Diseases 0.000 claims 2
- 229940038705 chlamydia trachomatis Drugs 0.000 claims 2
- 208000034391 chronic adult periodontitis Diseases 0.000 claims 2
- 208000001277 chronic periodontitis Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000019258 ear infection Diseases 0.000 claims 2
- 206010014665 endocarditis Diseases 0.000 claims 2
- 208000011323 eye infectious disease Diseases 0.000 claims 2
- 210000000744 eyelid Anatomy 0.000 claims 2
- 231100000479 fetal death Toxicity 0.000 claims 2
- 208000001786 gonorrhea Diseases 0.000 claims 2
- 229940047650 haemophilus influenzae Drugs 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 208000014674 injury Diseases 0.000 claims 2
- 230000000366 juvenile effect Effects 0.000 claims 2
- 210000004962 mammalian cell Anatomy 0.000 claims 2
- 230000007935 neutral effect Effects 0.000 claims 2
- 231100000252 nontoxic Toxicity 0.000 claims 2
- 230000003000 nontoxic effect Effects 0.000 claims 2
- 229940051027 pasteurella multocida Drugs 0.000 claims 2
- 244000052769 pathogen Species 0.000 claims 2
- 230000001717 pathogenic effect Effects 0.000 claims 2
- 201000001245 periodontitis Diseases 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 206010040872 skin infection Diseases 0.000 claims 2
- 125000000547 substituted alkyl group Chemical group 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 230000008733 trauma Effects 0.000 claims 2
- 201000008297 typhoid fever Diseases 0.000 claims 2
- 231100000397 ulcer Toxicity 0.000 claims 2
- 229940118696 vibrio cholerae Drugs 0.000 claims 2
- UNDUSVBXIVZGOQ-UHFFFAOYSA-N 1h-perimidin-2-amine Chemical group C1=CC(NC(N)=N2)=C3C2=CC=CC3=C1 UNDUSVBXIVZGOQ-UHFFFAOYSA-N 0.000 claims 1
- 241000606125 Bacteroides Species 0.000 claims 1
- 208000032841 Bulimia Diseases 0.000 claims 1
- 206010006550 Bulimia nervosa Diseases 0.000 claims 1
- 241000606161 Chlamydia Species 0.000 claims 1
- 241000555712 Forsythia Species 0.000 claims 1
- 201000008225 Klebsiella pneumonia Diseases 0.000 claims 1
- 241000589248 Legionella Species 0.000 claims 1
- 208000007764 Legionnaires' Disease Diseases 0.000 claims 1
- 241000606860 Pasteurella Species 0.000 claims 1
- 206010035717 Pneumonia klebsiella Diseases 0.000 claims 1
- 241001236193 Waddlia chondrophila Species 0.000 claims 1
- XSDQTOBWRPYKKA-UHFFFAOYSA-N amiloride Chemical group NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N XSDQTOBWRPYKKA-UHFFFAOYSA-N 0.000 claims 1
- 229960002576 amiloride Drugs 0.000 claims 1
- 244000052616 bacterial pathogen Species 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 208000025222 central nervous system infectious disease Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine group Chemical group NC(=N)N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 125000004437 phosphorous atom Chemical group 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 claims 1
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical group C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims 1
- 0 *C(/*(/*)=C(\*)/C(/*)=C(\*)/N)S(*)C(*)N(*)C1=C(*)C(*)(*)OC1=O Chemical compound *C(/*(/*)=C(\*)/C(/*)=C(\*)/N)S(*)C(*)N(*)C1=C(*)C(*)(*)OC1=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562151902P | 2015-04-23 | 2015-04-23 | |
| US62/151,902 | 2015-04-23 | ||
| PCT/CA2016/050470 WO2016168938A1 (en) | 2015-04-23 | 2016-04-22 | Derivatives of korormicin useful as antibiotics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021015712A Division JP7121225B2 (ja) | 2015-04-23 | 2021-02-03 | 抗生物質として有用なコロルマイシン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018513194A JP2018513194A (ja) | 2018-05-24 |
| JP2018513194A5 true JP2018513194A5 (enExample) | 2019-05-23 |
| JP6842089B2 JP6842089B2 (ja) | 2021-03-17 |
Family
ID=57142747
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017555587A Active JP6842089B2 (ja) | 2015-04-23 | 2016-04-22 | 抗生物質として有用なコロルマイシン誘導体 |
| JP2021015712A Active JP7121225B2 (ja) | 2015-04-23 | 2021-02-03 | 抗生物質として有用なコロルマイシン誘導体 |
| JP2022032136A Pending JP2022122857A (ja) | 2015-04-23 | 2022-03-02 | 抗生物質として有用なコロルマイシン誘導体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021015712A Active JP7121225B2 (ja) | 2015-04-23 | 2021-02-03 | 抗生物質として有用なコロルマイシン誘導体 |
| JP2022032136A Pending JP2022122857A (ja) | 2015-04-23 | 2022-03-02 | 抗生物質として有用なコロルマイシン誘導体 |
Country Status (8)
| Country | Link |
|---|---|
| US (5) | US10166213B2 (enExample) |
| EP (1) | EP3285762A4 (enExample) |
| JP (3) | JP6842089B2 (enExample) |
| CN (2) | CN116574132A (enExample) |
| AU (4) | AU2016253429B2 (enExample) |
| CA (1) | CA2983460A1 (enExample) |
| IL (2) | IL255182B2 (enExample) |
| WO (1) | WO2016168938A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016253429B2 (en) * | 2015-04-23 | 2019-01-03 | Viotika Life Sciences Inc. | Derivatives of korormicin useful as antibiotics |
| CN116617231B (zh) * | 2023-06-12 | 2024-11-15 | 沈阳药科大学 | 2-氨基萘嵌间二氮杂苯氢溴化物增强对革兰氏阴性菌杀菌作用的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2315489A (en) * | 1996-07-17 | 1998-02-04 | Merck & Co Inc | Antifungal agent |
| JP3905604B2 (ja) * | 1997-03-04 | 2007-04-18 | 株式会社海洋バイオテクノロジー研究所 | 新規化学物質コロールミシン |
| JP2000281670A (ja) | 1999-03-26 | 2000-10-10 | Marine Biotechnol Inst Co Ltd | 新規コロールミシン合成中間体及び製造法 |
| JP2000336088A (ja) * | 1999-05-27 | 2000-12-05 | Marine Biotechnol Inst Co Ltd | 新規化学物質Ｆ４２０ｍ類縁体 |
| JP2001010908A (ja) * | 1999-06-28 | 2001-01-16 | Marine Biotechnol Inst Co Ltd | 防汚剤 |
| JP2003061645A (ja) | 2001-08-23 | 2003-03-04 | Marine Biotechnol Inst Co Ltd | 海洋細菌の選択培地 |
| WO2008116029A1 (en) * | 2007-03-19 | 2008-09-25 | Wisconsin Alumni Research Foundation | Modulation of bacterial quorum sensing with synthetic ligands |
| EP2448930B1 (en) * | 2009-07-03 | 2017-02-15 | The National Institute for Biotechnology in the Negev Ltd. | N-((S)-2-Oxo-tetrahydro-furan-3-yl)-amide derivatives as inhibitors of the bacterial quorum sensing for treating plant or animal diseases and for preventing the formation of biofilms on medical devices |
| AU2016253429B2 (en) * | 2015-04-23 | 2019-01-03 | Viotika Life Sciences Inc. | Derivatives of korormicin useful as antibiotics |
-
2016
- 2016-04-22 AU AU2016253429A patent/AU2016253429B2/en not_active Ceased
- 2016-04-22 CN CN202310483500.4A patent/CN116574132A/zh active Pending
- 2016-04-22 WO PCT/CA2016/050470 patent/WO2016168938A1/en not_active Ceased
- 2016-04-22 EP EP16782435.8A patent/EP3285762A4/en not_active Ceased
- 2016-04-22 US US15/500,006 patent/US10166213B2/en active Active
- 2016-04-22 CN CN201680033925.3A patent/CN107708689A/zh active Pending
- 2016-04-22 CA CA2983460A patent/CA2983460A1/en active Pending
- 2016-04-22 IL IL255182A patent/IL255182B2/en unknown
- 2016-04-22 IL IL310102A patent/IL310102A/en unknown
- 2016-04-22 JP JP2017555587A patent/JP6842089B2/ja active Active
-
2018
- 2018-11-15 US US16/192,117 patent/US10744111B2/en active Active
-
2019
- 2019-04-02 AU AU2019202254A patent/AU2019202254B2/en not_active Ceased
-
2020
- 2020-07-15 US US16/930,178 patent/US11324716B2/en active Active
- 2020-11-11 AU AU2020267205A patent/AU2020267205B2/en not_active Ceased
-
2021
- 2021-02-03 JP JP2021015712A patent/JP7121225B2/ja active Active
-
2022
- 2022-03-02 JP JP2022032136A patent/JP2022122857A/ja active Pending
- 2022-04-27 US US17/660,886 patent/US12029716B2/en active Active
- 2022-07-08 AU AU2022204906A patent/AU2022204906B2/en not_active Ceased
-
2024
- 2024-07-08 US US18/766,386 patent/US20240358670A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012512262A5 (enExample) | ||
| FI76339B (fi) | Foerfarande foer framstaellning av som laekemedel anvaendbara 2-(1-imidoylpyrrolidin-3-yltio)-6-(1-hydroxietyl)-2- karbapenem-3-karboxylsyra och dess derivater. | |
| ES2287354T3 (es) | Antibioticos de accion dual. | |
| TWI535727B (zh) | 含有兒茶酚基之頭孢菌素類 | |
| Williams et al. | Asymmetric synthesis of 2, 6-diamino-6-(hydroxymethyl) pimelic acid: assignment of stereochemistry | |
| CN101715455A (zh) | 抗菌的1,4,5-取代的氨基糖苷类似物 | |
| RU2382026C2 (ru) | Аналоги липоксина а4 | |
| AU2003211113B2 (en) | Antibiotic conjugates | |
| JP2018513194A5 (enExample) | ||
| US5498632A (en) | Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antibacterial activity | |
| RU2100351C1 (ru) | Производные пиридонкарбоновой кислоты и композиция на их основе | |
| RU2013137752A (ru) | Твердые формы ингибитора гиразы (r)-1-этил-3-[6-фтор-5[2-(1-гидрокси-1-метил-этил) пиримидин-5-ил]-7-(тетрагидрофуран-2-ил)-1н-бензимидазол-2-ил] мочевины | |
| ITMI20080846A1 (it) | Composti a struttura glicosidica attivi nella terapia di stati infiammatori locali e sistemici | |
| JP2019089829A5 (enExample) | ||
| Neu | A symposium on the tetracyclines: a major appraisal. Introduction | |
| ES3030919T3 (en) | Bakuchiol derivative, pharmaceutically acceptable salt thereof, preparation method therefor and application thereof | |
| JP2016210683A (ja) | ヒドロキサム酸誘導体 | |
| CN102267953B (zh) | 合成头孢拉定或Cefroxadine的中间体化合物及其制备方法和应用 | |
| TW519542B (en) | Bicyclic amine derivative | |
| CN109503629B (zh) | 一种头孢唑肟酸的合成方法 | |
| JP2020508297A5 (enExample) | ||
| UA45414C2 (uk) | Похідні бензоксазиндіону, фармацевтична композиція на їх основі, спосіб посилення росту бактерій та спосіб лікування бактеріальної інфекції | |
| CN116462604B (zh) | 四种季铵盐衍生物的合成方法及其作为抗金黄色葡萄球菌感染的应用 | |
| CN113912484B (zh) | 1,4,6-三羟基-8-支链-9,10-蒽醌类化合物及在制备抑菌剂中的应用 | |
| JP2016210682A (ja) | ヒドロキサム酸誘導体 |